Top

Published in:

Open Access 01-05-2014 | Oral presentation

A Drosophila model linking diet-induced metabolic disease and cancer

Authors: Susumu Hirabayashi, Thomas Baranski, Ross Cagan

Published in: Cancer & Metabolism | Special Issue 1/2014

Excerpt

Epidemiological studies have provided strong evidence for the association between cancer and metabolic diseases including obesity and diabetes, but the underlying mechanism remains poorly understood. …

Musselman LP, Fink JL, Narzinski K, Ramachandran PV, Hathiramani SS, Cagan RL, Baranski TJ: A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila. Dis Model Mech. 2011, 4: 842-849. 10.1242/dmm.007948.PubMedCentralCrossRefPubMed

Na J, Musselman LP, Pendse J, Baranski TJ, Bodmer R, Ocorr K, Cagan R: A Drosophila model of high sugar diet-induced cardiomyopathy. PLoS Genet. 2013, 9: e1003175-10.1371/journal.pgen.1003175.PubMedCentralCrossRefPubMed

Hirabayashi S, Baranski TJ, Cagan RL: Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling. Cell. 2013, 154: 664-675. 10.1016/j.cell.2013.06.030.PubMedCentralCrossRefPubMed

Title: A Drosophila model linking diet-induced metabolic disease and cancer
Authors: Susumu Hirabayashi
Thomas Baranski
Ross Cagan
Publication date: 01-05-2014
Publisher: BioMed Central
Published in: Cancer & Metabolism / Issue Special Issue 1/2014
Electronic ISSN: 2049-3002
DOI: https://doi.org/10.1186/2049-3002-2-S1-O19

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2014

Regulation of growth and metabolism

Pioglitazone and thyroid cancer risk in patients with type 2 diabetes

Metabolic reprogramming by KSHV in cellular transformation

Investigating the role of inorganic phosphate in tumor metabolism and metastasis

AMPK regulated metabolic programing: oncogenic or growth suppressive? Evolving lessons from genetic and pharmacologic studies

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53 +/- mice

Keynote webinar | Spotlight on antibody–drug conjugates in cancer